Clostridium difficile infection: Description of NAP1/027 and non NAP1/027 strains in a high complexity center in Cali, Colombia, 2012-2015
Abstract
Introduction: Clostridium difficile causes nosocomial infections leading to high morbidity and mortality. The NAP1/027 strain is associated with a higher toxin production and disease severity, which increases the load of the disease.
Objective: To describe the epidemiology of the infections associated with C. difficile and the characteristics related to the NAP1/027 strain.
Materials and methods: This was an observational study based on the revision of clinical registries of patients with fecal samples that were positive for C. difficile identified by the Xpert test™ between 2012 and 2015 in a high complexity institution. The severity of the disease was evaluated by means of the ATLAS score.
Results: We included 42 infected cases, 9 of which were positive for the NAP1/027strain. The use of antibiotics previous to the infection for more than seven days was more frequent in patients with negative results for NAP1/027. The duration of diarrhea in half of the patients was longer than five days and there were no differences according to the type of strain (p>0.05). Positive cases for the NAP1/027 strain were characterized by presenting fetid and bloody stools. The severity of the infection was similar between the groups.
Conclusions: In Colombia, the NAP1/027 strain circulates without significant clinical differences, which could be due to the limited number of patients. Nevertheless, the existence of NAP1/027 should alert physicians and health institutions because of its high association with severity and mortality.
Downloads
References
Maggil S, Edwards J, Stat M, Bamberg W, Beldavs Z, Dumyati G, et al. Multistate pointprevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198-208. https://doi.org/10.1056/NEJMoa1306801
Leffler D, Lamont T. Clostridium difficile infections. N Engl J Med. 2015;372:1539-48. https://doi.org/10.1056/NEJMra1403772
Zea JW, Salazar CL. Enfermedad asociada a Clostridium difficile: prevalencia y diagnóstico por laboratorio. Infectio. 2012;16:211-22. https://doi.org/10.1016/S0123-9392(12)70016-4
Depestel DD, Aronoff DM. Epidemiology of Clostridium difficile infection. J Pharm Pract. 2013;26:464-75. https://doi.org/10.1177/0897190013499521
Rodríguez-Pardo D, Almirante B, Bartolome RM, Pomar V, Mirelis B, Navarro F, et al. Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: Results of a hospital-based study in Barcelona, Spain. J Clin Microbiol. 2013;51:1465-73. https://doi.org/10.1128/JCM.03352-12
Magee G, Strauss ME, Thomas SM, Brown H, Baumer D, Broderick KC. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011. Am J Infect Control. 2015;43:1148-53. https://doi.org/10.1016/j.ajic.2015.06.004
See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis. 2014;58:1394-400. https://doi.org/10.1093/cid/ciu125
Morfin-Otero R, Garza-González E, Aguirre-Díaz SA, Escobedo-Sánchez R, Esparza-Ahumada S, Pérez-Gómez HR, et al. Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital. Braz J Infect Dis. 2016;20:8-13. https://doi.org/10.1016/j.bjid.2015.09.008
Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH. Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol. 2012;50:4078-82. https://doi.org/10.1128/JCM.02291-12
Oñate-Gutiérrez J, Villegas M, Correa A. Prevalencia y factores relacionados con la infección por Clostridium difficile en un centro hospitalario de alta complejidad en Cali (Colombia). Infectio. 2017;21:9-14. https://doi.org/10.1016/j.infect.2015.12.002
Gualtero S, Abril LA, Camelo N, Sánchez SD, Silva E, Dávila FA, et al. Características de la infección por Clostridium difficile en una institución de alta complejidad y reporte de la circulación en Colombia de la cepa hipervirulenta NAP17027. Biomédica. 2017;37:7-12. https://doi.org/10.7705/biomedica.v37i4.3244
Otero-Regino W, González A, Gómez-Zuleta M. Prevalencia de diferentes tipos de colitis en personas adultas mayores. Revista Colombiana de Gastroenterología. 2009;24:272-8.
Becerra MG, Ospina S, Atehortúa SL, Berbesi DY. Factores de riesgo para la infección por Clostridium difficile. Infectio. 2011;15:220-6.
Cohen S, Gerding D, Johnson S, Kelly C, Loo V, McDonald L, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-55. https://doi.org/10.1086/651706
Hernández-García R, Garza-González E, Miller M, Arteaga-Muller G, Galván-de los Santos AM, Camacho-Ortiz A. Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in México. Braz J Infect Dis. 2015;19:399-402. https://doi.org/10.1016/j.bjid.2015.05.005
Miller MA, Louie T, Mullane K, Weiss K, Lentnek A, Golan Y, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis. 2013;13:148. https://doi.org/10.1186/1471-2334-13-148
Di X, Bai N, Zhang X, Liu B, Ni W, Wang J,et al. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile Infection, stratified by disease severity. Braz J Infect Dis. 2015;19:339-49. https://doi.org/10.1016/j.bjid.2015.03.006
Debast S, Bauer M, Kuijper E. European Society of Clinical Microbiology and Infectious Diseases: Update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(Suppl.2):1-26. https://doi.org/10.1111/1469-0691.12418
Mathur H, Rea MC, Cotter PD, Ross RP, Hill C. The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes. 2014;5:696-710. https://doi.org/10.4161/19490976.2014.983768
Some similar items:
- Sandra Milena Gualtero, Lina Alejandra Abril, Nathalia Camelo, Susi Daniela Sanchez, Fabián Antonio Davila, Gerson Arias, Edwin Silva, Ingrid Gissel Bustos, Diego Fernando Josa, Isabel Cristina Torres, Luis Carlos Zambrano, María José Pareja, Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia , Biomedica: Vol. 37 No. 4 (2017)
- Carlos Carvajal, Carlos Pacheco, Fabián Jaimes, Clinical and demographic profile and risk factors for Clostridium difficile infection , Biomedica: Vol. 37 No. 1 (2017)
- María Fernanda Gutiérrez, Sandra Moreno, Mónica Viviana Alvarado, Andrea Bermúdez, DNA sequence analysis indicates human origin of rotavirus and hepatitis A virus strains from western Colombia , Biomedica: Vol. 29 No. 2 (2009)
- Ana Luz Galván, Katherine Bedoya, Martha Nelly Montoya, Jorge Botero, Isolate of Encephalitozoon intestinalis from stools of a Colombian patient with AIDS , Biomedica: Vol. 28 No. 3 (2008)
- Nélida Muñoz, María Elena Realpe, Elizabeth Castañeda, Clara Inés Agudelo, Characterization by pulsed-field gel electrophoresis of Salmonella Typhimurium isolates recovered in the acute diarrheal disease surveillance program in Colombia, 1997-2004 , Biomedica: Vol. 26 No. 3 (2006)
- Iván Darío Flórez, Esteban Ramos, Carlos Bernal, Olga Juliana Cuéllar, José William Cornejo, Intravenous rehydration for diarrheal dehydration of eutrophic children: survey of protocols provided at Colombian medical schools , Biomedica: Vol. 31 No. 3 (2011)
- Andrés Leonardo González, Aura Lucía Leal, Jorge Alberto Cortés, Ricardo Sánchez, Liliana Isabel Barrero, Juan Sebastián Castillo, Carlos Arturo Álvarez, Effect of adequate initial antimicrobial therapy on mortality in critical patients with Pseudomonas aeruginosa bacteremia , Biomedica: Vol. 34 (2014): Abril, Suplemento 1, Resistencia bacteriana
- Ángela Liliana Londoño-Franco, Juliana Loaiza-Herrera, Fabiana María Lora-Suárez, Jorge Enrique Gómez-Marín, Blastocystis sp. frequency and sources among children from 0 to 5 years of age attending public day care centers in Calarcá, Colombia , Biomedica: Vol. 34 No. 2 (2014)
- Francy Novoa-Palomares , Laura Salas-Díaz , Cindy Pérez-Téllez , Ingred Pinillos-Medina, Orlando Torres-García, Felio J. Bello , Comparative analysis of the antimicrobial activity of larval secretions and excretions from Calliphora vicina and Sarconesiopsis magellanica (Diptera: Calliphoridae) , Biomedica: Vol. 42 No. 1 (2022)
- Victoria Eugenia Ángel, Liliana Franco, Juan Carlos Jaramillo, Luis Alfonso Medina, Francisco Luis Ochoa, Ana María Vélez, David Botero, Inés Helena Vásquez, Cryptosporidiosis en Medellín. Prevalencia de cryptosporidium en muestras fecales diarréicas en 6 laboratorios de Medellín, estudio de 10 casos , Biomedica: Vol. 5 No. 3-4 (1985)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
